Next Article in Journal
Cytotoxic and Bactericidal Effects of Inhalable Ciprofloxacin-Loaded Poly(2-ethyl-2-oxazoline) Nanoparticles with Traces of Zinc Oxide
Next Article in Special Issue
Physiological and Pathophysiological Roles of IgM Fc Receptor (FcµR) Isoforms
Previous Article in Journal
Liver Organoids as an In Vitro Model to Study Primary Liver Cancer
Previous Article in Special Issue
FcγRs and Their Relevance for the Activity of Anti-CD40 Antibodies
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
IJMS
Volume 24
Issue 5
10.3390/ijms24054531
ijms-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Evidence for Extensive Duplication and Subfunctionalization of FCRL6 in Armadillo (Dasypus novemcinctus)

by
Maria Carolina Matos
1,2,3,
Ana Pinheiro
1,2,
Randall S. Davis
4 and
Pedro J. Esteves
1,2,3,5,*
1
CIBIO-UP, Centro de Investigação em Biodiversidade e Recursos Genéticos, InBIO Laboratório Associado, Campus Agrário de Vairão, Universidade do Porto, 4485-661 Vairão, Portugal
2
BIOPOLIS Program in Genomics, Biodiversity and Land Planning, CIBIO, 4485-661 Vairão, Portugal
3
Departamento de Biologia, Faculdade de Ciências, Universidade do Porto, 4169-007 Porto, Portugal
4
Departments of Medicine, Microbiology, and Biochemistry & Molecular Genetics, Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL 35294, USA
5
CITS-Centro de Investigação em Tecnologias de Saúde, Cooperativa de Ensino Superior Politécnico e Universitário, CRL (CESPU), 4585-116 Gandra, Portugal
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2023, 24(5), 4531; https://doi.org/10.3390/ijms24054531
Submission received: 10 January 2023 / Revised: 17 February 2023 / Accepted: 21 February 2023 / Published: 25 February 2023
(This article belongs to the Special Issue Fc Receptors 2.0)
Browse Figures
Versions Notes

Abstract

:
The control of infections by the vertebrate adaptive immune system requires careful modulation to optimize defense and minimize harm to the host. The Fc receptor-like (FCRL) genes encode immunoregulatory molecules homologous to the receptors for the Fc portion of immunoglobulin (FCR). To date, nine different genes (FCRL1–6, FCRLA, FCRLB and FCRLS) have been identified in mammalian organisms. FCRL6 is located at a separate chromosomal position from the FCRL1-5 locus, has conserved synteny in mammals and is situated between the SLAMF8 and DUSP23 genes. Here, we show that this three gene block underwent repeated duplication in Dasypus novemcinctus (nine-banded armadillo) resulting in six FCRL6 copies, of which five appear functional. Among 21 mammalian genomes analyzed, this expansion was unique to D. novemcinctus. Ig-like domains that derive from the five clustered FCRL6 functional gene copies show high structural conservation and sequence identity. However, the presence of multiple non-synonymous amino acid changes that would diversify individual receptor function has led to the hypothesis that FCRL6 endured subfunctionalization during evolution in D. novemcinctus. Interestingly, D. novemcinctus is noteworthy for its natural resistance to the Mycobacterium leprae pathogen that causes leprosy. Because FCRL6 is chiefly expressed by cytotoxic T and NK cells, which are important in cellular defense responses against M. leprae, we speculate that FCRL6 subfunctionalization could be relevant for the adaptation of D. novemcinctus to leprosy. These findings highlight the species-specific diversification of FCRL family members and the genetic complexity underlying evolving multigene families critical for modulating adaptive immune protection.

1. Introduction

Adaptive immunity provides the core defense mechanism for controlling infections in vertebrates. However, antigen-specific responses require careful regulation to ensure that pathogens are neutralized without inadvertently harming the host [1]. The buffering and fine-tuning of adaptive responses is largely mediated by immunoregulatory molecules encoded by receptor-gene families that can promote and/or suppress reactivity. One example is the Fc receptor-like (FCRL) genes, which are linked by common ancestry to the IgG and IgE-binding classical Fc receptors (FCR) [1,2]. The FCR and the FCRL families not only share a similar structure and genetic organization, but also related extracellular Ig-like domains and an amino-terminal split signal peptide that consists of a 21 bp second exon that encodes the second half of the leader sequence [1,2,3,4]. Nine FCRL genes have been identified in mammalian genomes (FCRL1–6, FCRLA, FCRLB and FCRLS); however, not all are simultaneously present in all species. Based on human and mouse studies, most encode type I transmembrane glycoproteins that are restricted to B cells, with the exception of FCRL6 and FCRLS, which are expressed among different lymphocyte and myeloid lineages [5,6]. Despite their ectodomain similarity with the classical FCRs, the ligand binding properties of human FCRLs differ [1,3]. For example, secretory IgA is a ligand for FCRL3 [7], systemic IgA for FCRL4 [8,9], IgG for FCRL5 [9,10] and HLA/MHC class II molecules for FCRL6 [11]. The complexity of the FCRL family is underscored by genetic polymorphisms, multiple splice isoforms and tyrosine-based signaling features. While some family members have cytoplasmic sequences resembling immunoreceptor tyrosine-based activation motifs (ITAM), based on the high prevalence of immunoreceptor tyrosine-based inhibitory motifs (ITIM), FCRL1–6 appear to preferentially dampen immune responses [1,5]. Given their regulatory properties and lymphocyte-restricted distribution, there has been increasing interest in the associations of FCRLs with lymphoproliferative disorders, autoimmune diseases and immunodeficiencies [1,3,12,13,14,15,16,17]. These growing relationships collectively imply potential roles for these receptor-genes both in disease and as therapeutic targets.
In humans, FCRL6 encodes a type I surface glycoprotein with three Ig-like domains, a hydrophobic transmembrane segment, and a cytoplasmic tail with two tyrosines that constitute a consensus ITIM or a non-canonical ITAM (Table 1). FCRL6 is also distinguished by its chromosomal position apart from the FCRL1-5 locus and distribution outside the B cell lineage. FCRL6 transcripts are expressed by mature NK cells and cytotoxic T cells in the adult spleen and blood [1,3,16]. In the circulation, the FCRL6 protein is detected on more differentiated cytotoxic NK cells possessing high levels of cytoplasmic perforin [12,18,19]. However, in early functional work, FCRL6 did not appear to markedly influence NK cell degranulation, CD16-mediated killing or cytokine production [19,20]. Immunoprecipitation studies identified the recruitment of the SHP-2 phosphatase to the FCRL6 cytoplasmic tail, uncovering its potential inhibitory function in cytotoxic lymphocytes [19,20]. Furthermore, the discovery of MHCII/HLA-DR as a ligand indicated the existence of interactions between FCRL6-expressing effector lymphocytes and antigen-presenting cells or other cell types that express MHCII/HLA-DR [11]. Accordingly, MHCII/HLA-DR molecules can be endogenously upregulated by tumor cells in cancer patients [21]. This expression pattern is associated with positive responses to anti-PD-1 immune checkpoint inhibitor (ICI) therapy in multiple cancer types, including ovarian cancer, classical Hodgkin’s disease, and melanoma [22,23,24]. Yet, MHCII+ cancers can become resistant to chronic ICI therapy, adapting and exploiting alternative checkpoint pathways, one of which may include suppressing T and NK cell effector responses via LAG3 and/or FCRL6, both of which can interact with MHCII/HLA-DR [25].
CRL6 gene representatives are widely present in all mammalian families, including basal mammals such as elephants, pangolins, and armadillos. Armadillos belong to the Dasypodidae, the last extant family of the order [26,27,28,29,30,31,32,33]. Xenarthan placental mammals were first recorded among South American fossils in the Paleocene and are divided into three orders: the Cingulata, which includes armadillos; the Vermilingua, represented by anteaters; and the Phyllophaga suborder, that includes sloths [26,28,29,34]. Currently, there are 21 extant species of armadillos (Cingulata, Dasypodidae) [27,28,32,35,36,37,38]. These species primarily inhabit Central and South America, except for D. novemcinctus, which is more commonly known as the nine-banded armadillo and is found from Patagonia, Argentina, through to the southern United States [28,33,36]. As a result, D. novemcinctus is the most extensively spread Xenarthra species and has even been declared an invasive species by the US Department of Fish and Wildlife Services [28,33,36,38,39].
The armadillo has a number of characteristics that make it a relevant and useful research model. Most importantly, it exhibits susceptibility to leprosy, a human tropical disease mediated by the Mycobacterium leprae pathogen. Although this placental mammal has been defined as one of the best experimental models of leprosy, surprisingly, only about 5% of naturally infected animals develop clinical symptoms of the disease [40,41]. This observation suggests that D. novemcinctus may have undergone compensatory evolutionary immune adaption, resulting in the development of defense mechanisms that thwart M. leprae pathogenesis.
Here, we performed evolutionary analyses focused on the FCRL6 gene in mammals. The unique pattern of gene duplication and diversification observed for FCRL6 in D. novemcinctus is strongly suggestive of subfunctionalization, with intriguing relevance for the adaptation of this placental mammal in cell-mediated defense responses. These findings provide new insight into the immune system of this biological model and advance our understanding of the evolutionary importance of FCRL genes.

2. Results

2.1. Genomic Synteny Analysis of FCRL6 in Mammals

Compared to other FCRL family members, FCRL6 has widespread representation in mammals. For example, FCRL2 is absent in multiple genomes, including M. musculus, R. norvegicus, B. taurus, B. bubalis, Eptesicus fuscus and Myotis lucifugus [42]. However, an analysis of 21 mammalian genomes revealed that most possess a single copy of FCRL6, which is located in a conserved position between the SLAMF8 and DUSP23 genes (Figure 1). Surprisingly, we identified a massive block duplication of FCRL6 and its neighboring genes (SLAMF8 and DUSP23) in the D. novemcinctus genome. Figure 1 details five potentially functional copies of the FCRL6 gene and one pseudogene. Table 2 lists these D. novemcinctus FCRL6 gene replicates, which are listed A to F to simplify their nomenclature and relationships. Most copies, except for FCRL6C, are positioned with the SLAMF8 gene to the left and the DUSP23 gene to the right. They are also located in the telomeric region, a chromosomal region more prone to duplication, which supports the hypothesis of the block duplication of this genomic region. Despite the widespread representation of FCRL6 among the genomes analyzed, we also found evidence for high structural diversity, with different species having between one and three Ig-like domain-encoding exons, as shown in Table 1.

2.2. Phylogenetic and Evolutionary Analysis of FCRL6 in D. novemcinctus

We next analyzed the predicted D. novemcinctus FCRL6 genes to determine whether they: (1) possess primary structures, namely, Ig-like domains, conserved with FCRL6 representatives from other mammals, or (2) might be similar but different genes that resulted from the mutation, exon shuffling, or recombination of FCRL6 with neighboring gene(s) in this locus. The analysis of the exons from these species also revealed the hallmark 21 bp exon that constitutes the second half of the split signal peptide that characterizes the FCR and FCRL families [3]. We next performed a phylogenetic analysis using the five predicted functional D. novemcinctus FCRL6 cDNA sequences (copies A, C–F) identified by BLASTN, using a Maximum-Likelihood (ML) method and the T92 + G + I model of nucleotide substitution. The resulting ML phylogenetic tree supports the extensive duplication of the FCRL6 gene in D. novemcinctus, as indicated by the distinct grouping of the five copies from a subtree branch relative to 20 other mammalian FCRL6 representatives, with a bootstrap value of 100 (Figure 2). These findings indicate that the predicted D. novemcinctus FCRL6 genes are, in fact, all FCRL6 representatives. Collectively, these results support that all FCRL6 genes found in D. novemcintus are FCRL6 orthologs and are not distinct or related genes resulting from mutation, exon shuffling or recombination.

2.3. Protein Structure Analysis

We next investigated the structural and phylogenetic relationships of FCRL6 amino acid sequences predicted to encode type I proteins harboring Ig-like domains. An analysis of the five protein sequences from armadillo FCRL6A and C–F demonstrated similar interspecies structural variation to that previously observed in other mammals, including humans and rodents [3], with copies possessing either two or three Ig domains followed by a transmembrane region (Table 1). Specifically, FCRL6A, C, and F had two Ig-like domains, whereas FCRL6D and E had three. We then performed phylogenetic analyses of the amino acid sequences for these 12 FCRL6 Ig-like domains. The generation of ML trees revealed evidence for three different domain subtypes (D1–D3) among the five D. novemcinctus gene copies that were clustered in independent branches (Figure 3).
All domains grouped with high bootstraps (D1-100, D2-92 and D3-100) and in a membrane-distal to membrane-proximal fashion, as previously described [1,3]. Thus, the FCRL6 Ig-like domain subunits that are highly duplicated among the five gene copies in D. novemcinctus, but generally derive from single gene copies among most mammals, having evolved in a conserved manner as tandem exons-encoding domains in a similar membrane-proximal to -distal orientation. However, when we looked at the D. novemcinctus Ig-like domains, the D2 domains were grouped with the lowest bootstrap values. This prompted us to analyze the mean distance within each domain (Table 3). This approach disclosed that the D2 domain has the highest diversity compared to the other two domain types, sharing only 75.4% of the identity. Notably, this finding is in contrast to prior observations that FCRL Ig-like domains most distal to the transmembrane region generally have higher diversity and lower sequence identity [1,3].
An examination of the predicted intracellular regions of FCRL6A and C–F revealed that four out of the five copies had cytoplasmic tails, but FCRL6C did not. Prediction software indicated that it was unlikely that this representative is tethered to the plasma membrane by a glycosylphosphatidylinositol (GPI) anchor and glypiation [43]. To characterize the potential cellular location of FCRL6 copies in D. novemcinctus, each sequence was analyzed using the DeepLoc 2.0 server (Table 4) [44]. All FCRL6 copies appeared to be localized in the cell membrane, even the shorter FCRL6C representative.
Closer evaluation of the FCRL6A and D–F proteins showed the presence of potential cytoplasmic tyrosine-based motifs. Alignment of these sequences showed evidence of conservation with the human FCRL6 cytoplasmic tail, but remarkable inter-copy variation. An assessment of tyrosine-based ITIM (I/V/L-x-Y-x-x-L/V) or ITAM (D/Ex-x-Y-x-x-L/I-x6–8-Y-x-x-L/I) sequences [1,45,46], disclosed that these four representatives with long tails possessed consensus ITIM (Figure 4). However, while all sequences, have two histidine residues in the position 360 and 361, the D. novemcinctus A copy has one histidine replaced by a cysteine. Another peculiarity is found in copy D, where a glutamate (negatively charged) was lost and, instead of the 3 to 5 residues of threonine (polar and uncharged residue), 15 are present.
The number of extracellular cysteine residues present in the D. novemcinctus FCRL6 copies is mostly consistent (six to eight residues), with the exception of the C copy, which only has four residues. However, previous studies have determined that the human FCRL6 cysteines are unlikely to be involved in the homodimerization of the protein, so it is unclear if this intracellular cysteine has the potential to change the tridimensional conformation of this D. novemcinctus protein and affect its ability to be membrane-bound or segregated [20].

3. Discussion

Here, we identify evidence for marked FCRL6 expansion, duplication and subfunctionalization in D. novemcinctus. Among mammals, FCRL6 exhibits marked interspecies genetic variation (highlighted in Table 1). For example, the mouse and rat representatives have only two Ig domains and lack consensus ITIM or ITAM [3,47]. Despite these structural differences, the genomic synteny of the FCRL6 locus among mammalian lineages was largely maintained. In D. novemcinctus, this conserved synteny appears to be repeated in a three-gene block, with six copies of the FCRL6 gene each flanked on the left by SLAMF8 and on the right by DUSP23. One exception is FCRL6A, which is missing DUSP23 on the right, and FCRL6C, which is missing SLAMF8 on the left. Among these gene copies, only five appear to be functional, with one three-gene block replicate completely pseudogenized. Examining its chromosomal position among major mammalian families, it is evident in Homo sapiens, Mus musculus, Canis lupus familiaris, Felis catus and Bos taurus that the FCRL6 gene is always closer to the telomere, a region known to be rich in gene duplication [48]. Gene duplication is one of the driving forces of evolution and paralogs can either gather deleterious mutations, become subfunctionalized or become neofunctionalized [48]. The fact that Loxodonta africana has only one FCRL6 gene copy suggests that a duplication event did not occur in the Atlantogenata sister group, and thus may be exclusive to Xenarthra. However, based on the available genome sequences, all other Xenarthra species (Choloepus hoffmanni and Choloepus didactylus) seem to possess only one copy of the gene. Intriguingly, only single copies of SLAMF8 and DUSP23 at the distal ends of the locus appear to retain functionality, with all other replicates pseudogenized. Thus, this mass duplication of five potentially functional copies of FCRL6 appears to be exclusive to the D. novemcinctus species and could have marked functional impact.
Phylogenetic analysis at the cDNA level was revealing because the five FCRL6 copies in the armadillo were not only grouped with the other mammalian representatives, which lends support to the duplication hypothesis, but branched together independently. This latter finding is consistent with the subfunctionalization hypothesis for these five paralogous genes. At the protein level, phylogenetic analysis of the 12 FCRL6 Ig-like domains disclosed their relatedness with three mammalian FCRL6 Ig domain subtypes (D1–D3) by grouping in a conserved pattern according to their relative distance from the cell membrane. This further supports the hypothesis that these genes maintain functionality and may have acquired additional subfunctions during their evolution. However, in contrast to previous findings of membrane-distal FCRL Ig-like domains possessing the highest sequence diversity [2], in D. novemcinctus, D2 domains displayed the greatest diversity. This may indicate that the ligands for these receptors in this species are polymorphic.
Given that each FCRL6 copy possesses characteristic amino-terminal Ig domains, transmembrane regions and carboxy-terminal cytoplasmic tails, they are predicted to be type I membrane proteins. While the armadillo FCRL6C copy is annotated as a pseudogene in the NCBI database, we were able to translate and align its Ig-like domain sequences. Since it is the most divergent FCRL6 gene copy and located the most proximally to the pseudogenized copy, it is possible that FCRL6C is in the process of pseudogenization. This could explain its incomplete sequence in the Ensemble database. However, this replicate still retains the major characteristics that define FCRL6 receptors, despite lacking a cytoplasmic tail. Moreover, prediction software indicated that FCRL6C is most likely to be located in the cell membrane and not GPI-anchored.
Importantly, the D. novemcinctus FCRL6A and D–F copies all possess two cytoplasmic tyrosines. One of these tyrosine residues aligns with human FCRL6 and comprises a canonical ITIM. This finding indicates that, like human FCRL6, these four copies in D. novemcinctus could possess the capacity to recruit phosphatases that exert suppressive cellular function. Another notable intracellular feature in the A copy includes the change of a histidine residue to a cysteine, which might modify the tridimensional conformation or signaling properties of the cytoplasmic tail. Moreover, the D copy has an overrepresentation of cytoplasmic threonines, enriching a reactive amino acid that can establish hydrogen bonds with a large number of polar substrates and can be involved in phosphorylation.
These findings of four potential ITIM-bearing FCRL6 receptors in D. novemcinctus have led to the hypothesis that this marked expansion might impact immunoregulatory suppression and host tolerance to certain pathogens in these mammals. In humans, FCRL6 is expressed by effector T and NK lymphocytes and binds HLA-DR/MHCII on antigen-presenting cells (APC) such as B cells, dendritic cells, and macrophages [11]. Importantly, the nine-banded armadillo is known to be asymptomatic when infected by the intracellular parasite Trypanosoma cruzi, which enters macrophages during certain stages of its life cycle [49]. A second example is M. leprae, which also infects macrophages and dendritic cells and can produce up to 100 bacilli per cell [41,50]. However, armadillos have few discernible cutaneous signs of leprosy, with 15–20% of experimentally inoculated individuals being resistant and wild individuals in Texas, Florida and Mississippi having a rate of infection of between 0% and 29% [41,51]. Cytotoxic T cells have the ability to lyse APCs that are infected by M. leprae through the use of perforin and granzyme, which form pores in target cells and activate caspases that induce cell death [41,52]. NK cells are also recruited to leprosy lesions by IL-2, where they can clear and eliminate infected macrophages and Schwann cells [41]. Given the constrained pathogenicity of these two organisms, it is tempting to speculate that the additional FCRL6 copies evident in D. novemcinctus may confer this species tolerization against certain intracellular pathogens that invade APCs. If FCRL6 maintains a conserved expression pattern by effector lymphocytes in the armadillo, such expanded ITIM-mediated suppression in T and NK cells could curb cytotoxicity against the MHCII-expressing APCs that harbor these pathogens.
Evidence of a role for FCRL6 in tolerance and immune-evasion also comes from the tumor immunity. Studies of human solid tumors reveal that, similar to LAG3, FCRL6 is upregulated in malignancies that are MHCII/HLA-DR+ [12,25]. An analysis of the Cancer Genome Atlas (TCGA) RNA-sequencing data from non-hematopoietic cancer types disclosed that elevated FCRL6 expression in the tumor microenvironment correlates with improved overall survival and progression-free survival in melanoma, breast cancer and non-small cell lung cancer [12]. However, despite this favorability, some tumors may alternatively upregulate HLA-DR expression to blunt recognition by FCRL6-expressing cytotoxic cells and other immunoreceptors, as a strategy to tolerize effector lymphocyte responses and resist recognition and clearance [21]. Thus, further in vivo studies are required to better understand FCRL6 regulation and function in these contexts. However, this is somewhat complicated by its diversity among species, including humans and mice [12].
In summary, these newfound features of the FCRL6 immunoreceptor highlight the relevance of its interspecies divergence and evolutionary history. The identification of this distinct evolutionary event in D. novemcinctus should aid our understanding and hopefully uncover new functions for the FCRL6 receptor, especially with regard to its inhibitory function, role as a potential checkpoint target in tumor immunity and its involvement in host defense responses. These observations collectively imply a special role for FCRL6 at the interface of immune tolerance and defense.

4. Materials and Methods

Sequences. Mammalian FCRL6 gene sequences were obtained from Ensembl (https://www.ensembl.org/index.html (accessed on 10 November 2021)) and the NCBI GenBank (http://www.ncbi.nlm.nih.gov/genbank/ (accessed on 10 November 2021) [42,53]. The sequences were aligned using ClustalW [54] and BioEdit [55] software to identify intron/exon boundaries and open reading frames. The resulting alignments are available in the Supplementary Material (Files S1 and S2). Overall, 24 FCRL6 sequences from 20 species representative of the Primata, Rodentia, Lagomorpha, Artiodactyla, Carnivora and Proboscidea orders were analyzed (accession numbers are provided in Supplementary Table S1). The sequences that had frameshift deletions or insertions or/and premature stop codons were excluded.
Genomic Synteny Analysis. A map drawn to the approximate scale of the loci, including the inter- and intra-genic distances, was constructed to demonstrate the relative syntenic positions among genomes. Gene loci were determined using the Ensembl (https://www.ensembl.org/index.html (accessed on 10 November 2021) and NCBI (https://www.ncbi.nlm.nih.gov/gene/ (accessed on 10 November 2021) databases (provided in Supplementary Table S2).
Protein Structures. The SMART (Simple Modular Architecture Research Tool) web resource (http://smart.embl.de (accessed on 1 July 2022)), which interfaces with the UniProt, Ensembl and STRING protein databases, was used to identify and annotate FCRL6 protein domains for individual species [56,57]. To determine whether D. novemcinctus FCRL6 sequences were GPI-anchored, the NetGPI 1.1 [43] web tool (https://services.healthtech.dtu.dk/service.php?NetGPI-1.1 (accessed on 2 December 2022)) was used. This tool uses a deep learning approach, which is based on recurrent neural networks to predict glycosylphosphatidylinositol anchoring (GPI-anchoring or glypiation). To confirm if FCRL6 copies were present in the cell membrane, the DeepLoc 2.0 [44] web tool (https://services.healthtech.dtu.dk/service.php?DeepLoc (accessed on 2 December 2022)) was used. DeepLoc 2.0 is able to predict the subcellular localization of eukaryotic proteins using a Neural Networks algorithm trained on Uniprot proteins. To ensure the accuracy of the predictions, both full-length and exon-derived amino acid sequence segments were analyzed.
Phylogenetic Analysis. To determine the phylogenetic relationships between FCRL6 genes, MEGA version X 10.2.6 software [58] with a Maximum Likelihood (ML) framework was used. The Model Selection option in MEGA version X was used to determine the best fitting model for our datasets. For the analysis of full-length FCRL6 nucleotide sequences, the T92 + G + I model was used to construct the phylogenetic tree. To root the tree, FCRL3 sequences of Homo sapiens, Bos taurus, Oryctolagus cuniculus, Felis catus and Monodon monoceros were included, and node support was estimated using 1000 bootstrap replicates of ML trees. For the Ig-like domain amino acid analysis, an ML framework and the JTT + G model were applied to establish the relationship between the different domains of the sequences, with node support being estimated using 1000 bootstrap replicates of ML trees. The mean distances within Ig-like domain groups and between Ig-like domain groups were calculated using MEGAX.

5. Conclusions

This study brought to light the extensive duplication of the FCRL6 gene, which appears to be exclusive to the nine-banded armadillo. The synteny of this genomic location is preserved among mammals and the FCRL6 copies retain a conserved structure, which implies that these proteins might have undergone subfunctionalization as a result of their massive duplication. Importantly, four copies possess consensus ITIM in their cytoplasmic tails, but the D copy has an excess of threonine and the A copy has a histidine residue replaced by a cysteine, which may have important functional implications for the inhibitory properties of these receptors. The fact that this duplication is distinct to D. novemcinctus, which possesses symptomatic resistance to intracellular pathogens such as leprosy, has implications for host defense and tolerance. The hypothesis that an expansion of FCRL6 inhibitory receptor copies in armadillo effector lymphocytes may enhance host suppression, by binding MHCII-expressing antigen-presenting cells that are infected by M. leprae and curbing responses, requires further functional and expression studies.

Supplementary Materials

The supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/ijms24054531/s1.

Author Contributions

M.C.M. analyzed the data and wrote the manuscript. A.P. analyzed and discussed the data. R.S.D. discussed the data and edited the manuscript. P.J.E. conceived the study and discussed the data. All authors have read and agreed to the published version of the manuscript.

Funding

This work was co-funded by the project NORTE-01-0246-FEDER-000063, supported by Norte Portugal Regional Operational Programme (NORTE2020), under the PORTUGAL 2020 Partnership Agreement, through the European Regional Development Fund (ERDF). FCT also supported the post-doctoral fellowships of AP (SFRH/BPD/117451/2016) and the Investigator grant of PJE (CEECIND/CP1601/CT0005).

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

The dataset analysed in this study is available as supplementary material.

Conflicts of Interest

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.

References

  1. Ehrhardt, G.R.A.; Cooper, M.D. Immunoregulatory Roles for Fc Receptor-Like Molecules. In Negative Co-Receptors and Ligands; Ahmed, R., Honjo, T., Eds.; Springer: Berlin/Heidelberg, Germany, 2011; pp. 89–104. [Google Scholar]
  2. Davis, R.S.; Dennis, G., Jr.; Odom, M.R.; Gibson, A.W.; Kimberly, R.P.; Burrows, P.D.; Cooper, M.D. Fc receptor homologs: Newest members of a remarkably diverse Fc receptor gene family. Immunol. Rev. 2002, 190, 123–136. [Google Scholar] [CrossRef]
  3. Davis, R.S. Fc receptor-like molecules. Annu. Rev. Immunol. 2007, 25, 525–560. [Google Scholar] [CrossRef] [PubMed]
  4. Davis, R.S. FCRL regulation in innate-like B cells. Ann. N. Y. Acad. Sci. 2015, 1362, 110–116. [Google Scholar] [CrossRef]
  5. Akula, S.; Mohammadamin, S.; Hellman, L. Fc Receptors for Immunoglobulins and Their Appearance during Vertebrate Evolution. PLoS ONE 2014, 9, e96903. [Google Scholar] [CrossRef] [Green Version]
  6. Haage, V.; Semtner, M.; Vidal, R.O.; Hernandez, D.P.; Pong, W.W.; Chen, Z.; Hambardzumyan, D.; Magrini, V.; Ly, A.; Walker, J.; et al. Comprehensive gene expression meta-analysis identifies signature genes that distinguish microglia from peripheral monocytes/macrophages in health and glioma. Acta Neuropathol. Commun. 2019, 7, 20. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  7. Agarwal, S.; Kraus, Z.; Dement-Brown, J.; Alabi, O.; Starost, K.; Tolnay, M. Human Fc receptor-like 3 inhibits regulatory T cell function and binds secretory IgA. Cell Rep. 2020, 30, 1292–1299.e3. [Google Scholar] [CrossRef]
  8. Liu, Y.; Goroshko, S.; Leung, L.Y.; Dong, S.; Khan, S.; Campisi, P.; Propst, E.J.; Wolter, N.E.; Grunebaum, E.; Ehrhardt, G.R. FCRL4 Is an Fc Receptor for Systemic IgA, but Not Mucosal Secretory IgA. J. Immunol. 2020, 205, 533. [Google Scholar] [CrossRef] [PubMed]
  9. Wilson, T.J.; Fuchs, A.; Colonna, M. Cutting edge: Human FcRL4 and FcRL5 are receptors for IgA and IgG. J. Immunol. 2012, 188, 4741–4745. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  10. Franco, A.; Damdinsuren, B.; Ise, T.; Dement-Brown, J.; Li, H.; Nagata, S.; Tolnay, M. Human Fc receptor–like 5 binds intact IgG via mechanisms distinct from those of Fc receptors. J. Immunol. 2013, 190, 5739–5746. [Google Scholar] [CrossRef] [Green Version]
  11. Schreeder, D.M.; Cannon, J.P.; Wu, J.; Li, R.; Shakhmatov, M.A.; Davis, R.S. Cutting Edge: FcR-Like 6 Is an MHC Class II Receptor. J. Immunol. 2010, 185, 23. [Google Scholar] [CrossRef] [Green Version]
  12. Davis, R.S. Roles for the FCRL6 Immunoreceptor in Tumor Immunology. Front. Immunol. 2020, 11, 575175. [Google Scholar] [CrossRef]
  13. Li, X.; Gibson, A.W.; Kimberly, R.P. Human FcR polymorphism and disease. In Fc Receptors; Daeron, M., Nimmerjahn, F., Eds.; Springer International Publishing: Cham, Switzerland, 2014; pp. 275–302. [Google Scholar]
  14. Chistiakov, D.A.; Chistiakov, A.P. Is FCRL3 a New General Autoimmunity Gene? Hum. Immunol. 2007, 68, 375–383. [Google Scholar] [CrossRef] [PubMed]
  15. Kulemzin, S.V.; Zamoshnikova, A.Y.; Yurchenko, M.Y.; Vitak, N.Y.; Najakshin, A.M.; Fayngerts, S.A.; Chikaev, N.A.; Reshetnikova, E.S.; Kashirina, N.M.; Peclo, M.M.; et al. FCRL6 receptor: Expression and associated proteins. Immunol. Lett. 2011, 134, 174–182. [Google Scholar] [CrossRef]
  16. Davis, R.S.; Ehrhardt, G.R.; Leu, C.M.; Hirano, M.; Cooper, M.D. An extended family of Fc receptor relatives. Eur. J. Immunol. 2005, 35, 674–680. [Google Scholar] [CrossRef] [PubMed]
  17. Siewe, B.; Nipper, A.J.; Sohn, H.; Stapleton, J.T.; Landay, A. FcRL4 Expression Identifies a Pro-inflammatory B Cell Subset in Viremic HIV-Infected Subjects. Front. Immunol. 2017, 8, 1339. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  18. Li, F.J.; Won, W.J.; Becker, E.J.; Easlick, J.L.; Tabengwa, E.M.; Li, R.; Shakhmatov, M.; Honjo, K.; Burrows, P.D.; Davis, R.S. Emerging Roles for the FCRL Family Members in Lymphocyte Biology and Disease. In Fc Receptors; Daeron, M., Nimmerjahn, F., Eds.; Springer International Publishing: Cham, Switzerland, 2014; pp. 29–50. [Google Scholar]
  19. Schreeder, D.M.; Pan, J.; Li, F.J.; Vivier, E.; Davis, R.S. FCRL6 distinguishes mature cytotoxic lymphocytes and is upregulated in patients with B-cell chronic lymphocytic leukemia. Eur. J. Immunol. 2008, 38, 3159–3166. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  20. Wilson, T.J.; Presti, R.M.; Tassi, I.; Overton, E.T.; Cella, M.; Colonna, M. FcRL6, a new ITIM-bearing receptor on cytolytic cells, is broadly expressed by lymphocytes following HIV-1 infection. Blood 2007, 109, 3786–3793. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  21. Axelrod, M.L.; Cook, R.S.; Johnson, D.B.; Balko, J.M. Biological Consequences of MHC-II Expression by Tumor Cells in Cancer. Clin. Cancer Res. 2019, 25, 2392–2402. [Google Scholar] [CrossRef]
  22. Johnson, D.; Estrada, M.V.; Salgado, R.; Sanchez, V.; Doxie, D.B.; Opalenik, S.R.; Vilgelm, A.E.; Feld, E.; Johnson, A.S.; Greenplate, A.R.; et al. Melanoma-specific MHC-II expression represents a tumour-autonomous phenotype and predicts response to anti-PD-1/PD-L1 therapy. Nat. Commun. 2016, 7, 10582. [Google Scholar] [CrossRef] [Green Version]
  23. Roemer, M.G.; Redd, R.A.; Cader, F.Z.; Pak, C.J.; Abdelrahman, S.; Ouyang, J.; Sasse, S.; Younes, A.; Fanale, M.; Santoro, A.; et al. Major histocompatibility complex class II and programmed death ligand 1 expression predict outcome after programmed death 1 blockade in classic Hodgkin lymphoma. J. Clin. Oncol. 2018, 36, 942. [Google Scholar] [CrossRef]
  24. Callahan, M.J.; Nagymanyoki, Z.; Bonome, T.; Johnson, M.E.; Litkouhi, B.; Sullivan, E.H.; Hirsch, M.S.; Matulonis, U.A.; Liu, J.; Birrer, M.J.; et al. Increased HLA-DMB expression in the tumor epithelium is associated with increased CTL infiltration and improved prognosis in advanced-stage serous ovarian cancer. Clin. Cancer Res. 2008, 14, 7667–7673. [Google Scholar] [CrossRef] [Green Version]
  25. Johnson, D.B.; Nixon, M.J.; Wang, Y.; Wang, D.Y.; Castellanos, E.; Estrada, M.V.; Ericsson-Gonzalez, P.I.; Cote, C.H.; Salgado, R.; Sanchez, V.; et al. Tumor-specific MHC-II expression drives a unique pattern of resistance to immunotherapy via LAG-3/FCRL6 engagement. JCI Insight 2018, 3, e120360. [Google Scholar] [CrossRef] [Green Version]
  26. Barlow, J. Xenarthrans and pholidotes. In Orders and Families of Recent Mammals of the World; John Wiley & Sons, Inc.: New York, NY, USA, 1984; pp. 219–239. [Google Scholar]
  27. Wilson, D.; Reeder, D. The checklist of mammal names. In Mammal Species of the World; Johns Hopkins University Press: Baltimore, MD, USA, 2005. [Google Scholar]
  28. Shapiro, B.; Graham, R.W.; Letts, B. A revised evolutionary history of armadillos (Dasypus) in North America based on ancient mitochondrial DNA. Boreas 2015, 44, 14–23. [Google Scholar] [CrossRef]
  29. Rose, K.D. The Rise of Placental Mammals: Origins and Relationships of the Major Extant Clades; JHU Press: Baltimore, MD, USA, 2005. [Google Scholar]
  30. Delsuc, F.; Catzeflis, F.M.; Stanhope, M.J.; Douzery, E.J. The evolution of armadillos, anteaters and sloths depicted by nuclear and mitochondrial phylogenies: Implications for the status of the enigmatic fossil Eurotamandua. Proc. R. Soc. Lond. Ser. B Biol. Sci. 2001, 268, 1605–1615. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  31. Rose, K.; Gaudin, T. Xenarthra and Pholidota (armadillos, anteaters, sloths and pangolins). In eLS; John Wiley & Sons, Inc.: New York, NY, USA; Hoboken, NJ, USA, 2010. [Google Scholar]
  32. Parker, S.P. Grzimek’s Encyclopedia of Mammals; McGraw-Hill: New York, NY, USA, 1990; Volume 3. [Google Scholar]
  33. McBee, K.; Baker, R.J. Dasypus novemcinctus. Mamm. Species 1982, 162, 1–9. [Google Scholar] [CrossRef]
  34. Marshall, L.G.; Webb, S.D.; Sepkoski, J.J.; Raup, D.M. Mammalian Evolution and the Great American Interchange. Science 1982, 215, 1351–1357. [Google Scholar] [CrossRef] [PubMed]
  35. Abba, A.M.; Superina, M. The 2009/2010 armadillo red list assessment. Edentata 2010, 11, 135–184. [Google Scholar] [CrossRef] [Green Version]
  36. Loughry, W.J.; Superina, M.; McDonough, C.M.; Abba, A.M. Research on armadillos: A review and prospectus. J. Mammal. 2015, 96, 635–644. [Google Scholar] [CrossRef] [Green Version]
  37. Möller-Krull, M.; Delsuc, F.; Churakov, G.; Marker, C.; Superina, M.; Brosius, J.; Douzery, E.J.; Schmitz, J. Retroposed elements and their flanking regions resolve the evolutionary history of xenarthran mammals (armadillos, anteaters, and sloths). Mol. Biol. Evol. 2007, 24, 2573–2582. [Google Scholar] [CrossRef]
  38. Vizcaíno, S.; Milne, N. Structure and function in armadillo limbs (Mammalia: Xenarthra: Dasypodidae). J. Zool. 2002, 257, 117–127. [Google Scholar] [CrossRef]
  39. Simonson, S.; Barnett, D.; Stohlgren, T. The Invasive Species Survey: A Report on the Invasion of the National Wildlife Refuge System; National Institute of Invasive Species Science Technical Report: Fort Collins, CO, USA, 2004.
  40. Oliveira, I.V.P.D.M.; Deps, P.D.; Antunes, J.M.A.D.P. Armadillos and leprosy: From infection to biological model. Rev. Inst. Med. Trop. São Paulo 2019, 61, e44. [Google Scholar] [CrossRef]
  41. Scollard, D.M.; Adams, L.B.; Gillis, T.P.; Krahenbuhl, J.L.; Truman, R.W.; Williams, D.L. The continuing challenges of leprosy. Clin. Microbiol. Rev. 2006, 19, 338–381. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  42. Matos, M.C.; Pinheiro, A.; Melo-Ferreira, J.; Davis, R.S.; Esteves, P.J. Evolution of Fc Receptor-Like Scavenger in Mammals. Front. Immunol. 2021, 11, 590280. [Google Scholar] [CrossRef]
  43. Gíslason, M.H.; Nielsen, H.; Almagro Armenteros, J.J.; Johansen, A.R. Prediction of GPI-anchored proteins with pointer neural networks. Curr. Res. Biotechnol. 2021, 3, 6–13. [Google Scholar] [CrossRef]
  44. Thumuluri, V.; Almagro Armenteros, J.J.; Johansen, A.R.; Nielsen, H.; Winther, O. DeepLoc 2.0: Multi-label subcellular localization prediction using protein language models. Nucleic Acids Res. 2022, 50, W228–W234. [Google Scholar] [CrossRef]
  45. Vély, F.; Vivier, E. Conservation of structural features reveals the existence of a large family of inhibitory cell surface receptors and noninhibitory/activatory counterparts. J. Immunol. 1997, 159, 2075–2077. [Google Scholar] [CrossRef]
  46. Ravetch, J.V.; Lanier, L.L. Immune Inhibitory Receptors. Science 2000, 290, 84–89. [Google Scholar] [CrossRef] [PubMed]
  47. Honjo, K.; Won, W.-J.; King, R.G.; Ianov, L.; Crossman, D.K.; Easlick, J.L.; Shakhmatov, M.A.; Khass, M.; Vale, A.M.; Stephan, R.P.; et al. Fc Receptor-Like 6 (FCRL6) discloses progenitor B cell heterogeneity that correlates with pre-BCR dependent and independent pathways of natural antibody selection. Front. Immunol. 2020, 11, 82. [Google Scholar] [CrossRef]
  48. Wong, A.; Vallender, E.J.; Heretis, K.; Ilkin, Y.; Lahn, B.T.; Martin, C.L.; Ledbetter, D.H. Diverse fates of paralogs following segmental duplication of telomeric genes. Genomics 2004, 84, 239–247. [Google Scholar] [CrossRef]
  49. Diniz, L.; Costa, E.; Oliveira, P. Clinical disorders in armadillos (Dasypodidae, Edentata) in captivity. J. Vet. Med. Ser. B 1997, 44, 577–582. [Google Scholar] [CrossRef]
  50. Hagge, D.A.; Ray, N.A.; Krahenbuhl, J.L.; Adams, L.B. An In Vitro Model for the Lepromatous Leprosy Granuloma: Fate of Mycobacterium leprae from Target Macrophages after Interaction with Normal and Activated Effector Macrophages. J. Immunol. 2004, 172, 7771. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  51. Ploemacher, T.; Faber, W.R.; Menke, H.; Rutten, V.; Pieters, T. Reservoirs and transmission routes of leprosy; A systematic review. PLoS Negl. Trop. Dis. 2020, 14, e0008276. [Google Scholar] [CrossRef] [PubMed]
  52. Kaleab, B.; Ottenoff, T.; Converse, P.; Halapi, E.; Tadesse, G.; Rottenberg, M.; Kiessling, R. Mycobacterial-induced cytotoxic T cells as well as nonspecific killer cells derived from healthy individuals and leprosy patients. Eur. J. Immunol. 1990, 20, 2651–2659. [Google Scholar] [CrossRef]
  53. Pinheiro, A.; Águeda-Pinto, A.; Melo-Ferreira, J.; Neves, F.; Abrantes, J.; Esteves, P.J. Analysis of substitution rates showed that TLR5 is evolving at different rates among mammalian groups. BMC Evol. Biol. 2019, 19, 221. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  54. Thompson, J.D.; Higgins, D.G.; Gibson, T.J. CLUSTAL W: Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 1994, 22, 4673–4680. [Google Scholar] [CrossRef] [Green Version]
  55. Hall, T.A. BioEdit: A user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. In Nucleic Acids Symposium Series; Information Retrieval Ltd.: London, UK, 1999; pp. c1979–c2000. [Google Scholar]
  56. Letunic, I.; Bork, P. 20 years of the SMART protein domain annotation resource. Nucleic Acids Res. 2017, 46, D493–D496. [Google Scholar] [CrossRef]
  57. Letunic, I.; Khedkar, S.; Bork, P. SMART: Recent updates, new developments and status in 2020. Nucleic Acids Res. 2020, 49, D458–D460. [Google Scholar] [CrossRef]
  58. Kumar, S.; Stecher, G.; Li, M.; Knyaz, C.; Tamura, K. MEGA X: Molecular evolutionary genetics analysis across computing platforms. Mol. Biol. Evol. 2018, 35, 1547. [Google Scholar] [CrossRef]
Ijms 24 04531 g001 550
Figure 1. Structure of the FCRL6 locus among 11 mammalian genomes. Horizontal lines correspond to the chromosome on which FCRL6 and its flanking genes are located. Genes are color-coded: FCRL6 (red), SLAMF8 (purple), VSIG8 (blue), DUSP23 (yellow) and SH2B (green). Pseudogenes are labelled with an asterisk (*).
Figure 1. Structure of the FCRL6 locus among 11 mammalian genomes. Horizontal lines correspond to the chromosome on which FCRL6 and its flanking genes are located. Genes are color-coded: FCRL6 (red), SLAMF8 (purple), VSIG8 (blue), DUSP23 (yellow) and SH2B (green). Pseudogenes are labelled with an asterisk (*).
Ijms 24 04531 g001
Ijms 24 04531 g002 550
Figure 2. Phylogenetic analysis comparing representative mammalian and D. novemcinctus FCRL6 cDNA sequences. The maximum likelihood (ML) method and the T92 + G + I model of nucleotide substitution were used to assemble the phylogenetic tree. Some groups were collapsed for simplification. The tree includes FCRL6 genes from D. novemcinctus (n = 5) (red), FCRL6 genes from other indicated mammals (n = 20) (black), and was rooted with FCRL3 (H. sapiens, B. taurus, O. cuniculus, F. catus and M. monocero) (green). Bootstrap values are indicated to the left of each node.
Figure 2. Phylogenetic analysis comparing representative mammalian and D. novemcinctus FCRL6 cDNA sequences. The maximum likelihood (ML) method and the T92 + G + I model of nucleotide substitution were used to assemble the phylogenetic tree. Some groups were collapsed for simplification. The tree includes FCRL6 genes from D. novemcinctus (n = 5) (red), FCRL6 genes from other indicated mammals (n = 20) (black), and was rooted with FCRL3 (H. sapiens, B. taurus, O. cuniculus, F. catus and M. monocero) (green). Bootstrap values are indicated to the left of each node.
Ijms 24 04531 g002
Ijms 24 04531 g003 550
Figure 3. Phylogenetic tree of the predicted amino acid sequences for FCRL6 Ig domains from D. novemcinctus and a panel of mammals (n = 20). The maximum likelihood (ML) method and the JTT + G + I model of amino acid substitution were used for analysis and assembly. D1 corresponds to the membrane-distal Ig-like domain, D2 to a middle Ig-like domain, D3 to a membrane-proximal Ig-like domain.
Figure 3. Phylogenetic tree of the predicted amino acid sequences for FCRL6 Ig domains from D. novemcinctus and a panel of mammals (n = 20). The maximum likelihood (ML) method and the JTT + G + I model of amino acid substitution were used for analysis and assembly. D1 corresponds to the membrane-distal Ig-like domain, D2 to a middle Ig-like domain, D3 to a membrane-proximal Ig-like domain.
Ijms 24 04531 g003
Ijms 24 04531 g004 550
Figure 4. Multiple sequence alignment of the human and nine-band armadillo FCRL6 cytoplasmic tails. Marked are potential tyrosine-based activating and inhibitory sequences, along with cysteine, histidine and threonine residues. Alignment was performed using CLUSTALW in the BioEdit software package. An ITAM-like sequence (H. sapiens) is colored green and ITIM are red. Cysteines are in black, bold and highlighted grey. Histidine is highlighted green. Threonine is highlighted yellow.
Figure 4. Multiple sequence alignment of the human and nine-band armadillo FCRL6 cytoplasmic tails. Marked are potential tyrosine-based activating and inhibitory sequences, along with cysteine, histidine and threonine residues. Alignment was performed using CLUSTALW in the BioEdit software package. An ITAM-like sequence (H. sapiens) is colored green and ITIM are red. Cysteines are in black, bold and highlighted grey. Histidine is highlighted green. Threonine is highlighted yellow.
Ijms 24 04531 g004
Table
Table 1. Predicted domains, repeats, motifs and features of Fc receptor-like 6 (FCRL6) among a panel of mammalian species (http://smart.embl-heidelberg.de/ (accessed on 1 July 2022)). IG, immunoglobulin domain (green); IGc2, immunoglobulin C-2 type domain (dark green); IG-like, Immunoglobulin-like (light green); transmembrane region (dark blue rectangle); low complexity region (light blue rectangle).
Table 1. Predicted domains, repeats, motifs and features of Fc receptor-like 6 (FCRL6) among a panel of mammalian species (http://smart.embl-heidelberg.de/ (accessed on 1 July 2022)). IG, immunoglobulin domain (green); IGc2, immunoglobulin C-2 type domain (dark green); IG-like, Immunoglobulin-like (light green); transmembrane region (dark blue rectangle); low complexity region (light blue rectangle).
SpeciesFCRL6
ArmadilloACDEF
Ijms 24 04531 i001Ijms 24 04531 i002Ijms 24 04531 i003Ijms 24 04531 i004Ijms 24 04531 i005
HumanIjms 24 04531 i006--------------------------------------------------------------------------------------------
House mouseIjms 24 04531 i007--------------------------------------------------------------------------------------------
Brown ratIjms 24 04531 i008--------------------------------------------------------------------------------------------
DogIjms 24 04531 i009--------------------------------------------------------------------------------------------
European rabbitIjms 24 04531 i010--------------------------------------------------------------------------------------------
CattleIjms 24 04531 i011--------------------------------------------------------------------------------------------
CatIjms 24 04531 i012--------------------------------------------------------------------------------------------
Malayan pangolinIjms 24 04531 i013--------------------------------------------------------------------------------------------
Chinese pangolinIjms 24 04531 i014--------------------------------------------------------------------------------------------
Table
Table 2. Proposed nomenclature for FCRL6 gene copies in D. novemcinctus.
Table 2. Proposed nomenclature for FCRL6 gene copies in D. novemcinctus.
Proposed NomenclatureGene SymbolDNA Accession NumberProtein Accession Number
ALOC101434982XM023588041.1XP_023443809.1
B (pseudogenized)LOC105745885--------------------------------------------------
CENSDNOG00000034278ENSDNOT00000037015.1ENSDNOP00000030820
DLOC105745887XM023588042.1XP_023443810.1
ELOC101436671XM023588037.1XP_023443805.1
FLOC101437529XM012524200.1XP_012379654.1
Table
Table 3. Mean within-group distances (D1, D2 and D3) of the D. novemcinctus Ig-like ectodomains calculated in MEGAX.
Table 3. Mean within-group distances (D1, D2 and D3) of the D. novemcinctus Ig-like ectodomains calculated in MEGAX.
GroupMean Distance
D10.124
D20.246
D30.145
Table
Table 4. Subcelullar localizations of FCRL6A and C–F in D. novemcinctus predicted by DeepLoc 2.0.
Table 4. Subcelullar localizations of FCRL6A and C–F in D. novemcinctus predicted by DeepLoc 2.0.
Location
IsoformCytoplasmNucleusExtracellularCell
Membrane		MitochondrionPlastidEndoplasmic
Reticulum		Lysosome/
Vacuole		Golgi
Apparatus		Peroxisome
A0.30080.11250.15640.84830.04020.00320.29720.37230.33150.1876
C0.25550.10320.23190.82210.06210.00650.46570.24570.34610.1602
D0.27640.08380.17960.87350.04820.00180.31500.32180.31900.1497
E0.29430.09790.14630.82730.03800.00180.30750.31330.33560.1138
F0.25630.08380.16720.85120.02720.00300.25970.31180.30980.1463
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Matos, M.C.; Pinheiro, A.; Davis, R.S.; Esteves, P.J. Evidence for Extensive Duplication and Subfunctionalization of FCRL6 in Armadillo (Dasypus novemcinctus). Int. J. Mol. Sci. 2023, 24, 4531. https://doi.org/10.3390/ijms24054531

AMA Style

Matos MC, Pinheiro A, Davis RS, Esteves PJ. Evidence for Extensive Duplication and Subfunctionalization of FCRL6 in Armadillo (Dasypus novemcinctus). International Journal of Molecular Sciences. 2023; 24(5):4531. https://doi.org/10.3390/ijms24054531

Chicago/Turabian Style

Matos, Maria Carolina, Ana Pinheiro, Randall S. Davis, and Pedro J. Esteves. 2023. "Evidence for Extensive Duplication and Subfunctionalization of FCRL6 in Armadillo (Dasypus novemcinctus)" International Journal of Molecular Sciences 24, no. 5: 4531. https://doi.org/10.3390/ijms24054531

APA Style

Matos, M. C., Pinheiro, A., Davis, R. S., & Esteves, P. J. (2023). Evidence for Extensive Duplication and Subfunctionalization of FCRL6 in Armadillo (Dasypus novemcinctus). International Journal of Molecular Sciences, 24(5), 4531. https://doi.org/10.3390/ijms24054531

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop